Publications
Year 2012:
Kovářová J.T., Zavoral M., Zima T., Žák A., Kocna P., Kohout P., Granátová J., Vaníčková Z., Vránová J., Suchánek S., Beneš Z., Čelko M.A., Povýšil C.: Improvements in colorectal cancer screening programmes – quantitative immunochemical faecal occult blood testing – how to set the cut-off for a particular population. Biomed Pap 2012, 156(2):143-150 - PDF soubor
Year 2011:
Was H., Sokolowska M., Sierpinowska A., Dominik P., Skrzypek K., Lackowska B., Pratnicki A., Grochot-Przeczek A., Taha H., Kotlinowski J., Kozakowska M., Mazan A., Nowak W., Muchová L., Vitek L., Ratajska A., Dulak J., Jozkowicz A. Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice. Free Radic Biol Med 2011; 51(9):1717-1726
Vítek L, Muchová L, Zák A. Statin use and serum bilirubin levels. Atherosclerosis 2011;219:969.
Urbánek P, Leníček M, Muchová L, Subhanová I, Dušek L, Kaspříková N, Hrabal P, Bruha R, Vítek L: No association of promoter variations of HMOX1 and UGT1A1 genes with liver injury in chronic hepatitis C. Ann Hepatol. 2011, 10(4):445-51. IF = 1,811.
Šmíd F., Ledvinová J., Petr T., Šmídová J., Vítek L.: Methods based on binding affinity of the B-subunit of cholera toxin to gangliosides in biochemistry and histology. Nova Science Publishers, Inc., New York 2011, str. 89 -108
Muchova L, Vanova K, Zelenka J, Lenicek M, Petr T, Vejrazka M, Sticova E, Vreman HJ, Wong RJ, Vitek L. Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress. J Cell Mol Med 2011;15:1156-1165. IF = 4,125.
Hradský O, Dušátková P, Leníček M, Bronský J, Ďuricová D, Nevoral J, Vítek L, Lukáš M, Cinek O. Two independent genetic factors responsible for the associations of the IBD5 locus with Crohn’s disease in the Czech population. Inflamm Bowel Dis 2011;17(7): 1523-9. IF = 4,855.
Leníček M, Ďuricová D, Komárek V, Gabryšová B, Lukáš M, Šmerhovský Z, Vítek L. Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers. Inflamm Bowel Dis 2011;17(6):1322-1327. IF = 4,855.
Gutiérrez-Grobe Y, Vitek L, Tiribelli C, Kobashi-Margáin RA, Uribe M, Méndez-Sánchez N. Biliverdin and heme oxygenase antiviral activity against hepatitis C virus. Ann Hepatol 2011;10:105-7.
Gabrovská D., Kocna P., Rysová J., Borovská D.,Tlaskalová-Hogenová H.: Monitoring of Daily Gliadin Intake in Patients on Gluten-free Diets. Prague Medical Report 2011, 112 (1): 5 – 17 PDF soubor
Fode P, Jespersgaard C, Hardwick RJ, Bogle H, Theisen M, Dodoo D, Leníček M, Vítek L, Vieira A, Freitas J, Andersen PS, Hollox EJ. Determination of Beta-defensin genomic copy number in different populations: a comparison of three methods. PLoS One 2011;6(2):e16768. IF = 4,092.
Duricova D, Jakobín C, Lenicek M, Lukas M, Munkholm P, Pedersen N, Weber V: The clinical implication of drug dependency in children and adults with inflammatory bowel disease: A review. Journal of Crohn's and Colitis 2011; Vol. 5, Issue 2: 81-90. IF = 2,566.
Černý D, Lekić N, Váňová K, Muchová L, Hořínek A, Kmoníčková E, Zídek Z, Kameníková L, Farghali H: Hepatoprotective effect of curcumin in lipopolysaccharide/D-galactosamine model of liver injury in rats: Relationship to HO-1/CO antioxidant system, Fitoterapia 2011;82:786–791.
Year 2010:
Lenicek M, Duricova D, Komarek V, Gabrysova B, Lukas M, Smerhovsky Z, Vitek L.: Bile acid malabsorption in inflammatory bowel disease: Assessment by serum markers. Inflamm Bowel Dis 2011 Jun;17(6):1322-7. doi: 10.1002/ibd.21502. Epub 2010 Nov 5. IF = 4,643
Bruha R, Marecek Z, Pospisilova L, Nevsimalova S, Vitek L, Martasek P, Nevoral J, Petrtyl J, Urbanek P, Jiraskova A, Ferenci P.: Long-term follow-up of Wilson Disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver Int. 2011 Jan;31(1):83-91. doi: 10.1111/j.1478-3231.2010.02354.x. Epub 2010 Oct 20. IF = 2,987
Nevsimalova S, Buskova J, Bruha R, Kemlink D, Sonka K, Vitek L, Marecek Z Sleep disorders in Wilson's disease. Eur J Neurol. 2011 Jan;18(1):184-90. doi: 10.1111/j.1468-1331.2010.03106.x.. IF = 2,510
Meggyesi N, Kiss LS, Koszarska M, Bortlik M, Duricova D, Lakatos L, Molnar T, Leniček M, Vítek L, Altorjay I, Papp M, Tulassay Z, Miheller P, Papp J, Tordai A, Andrikovics H, Lukas M, Lakatos PL. NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients. World J Gastroenterol 2010;16:5233-40. IF=2,092
Vítek L. Elevated bilirubin in acute and transient psychotic disorder. Pharmacopsychiatry 2010;43:285. IF = 2,317
Pedersen N, Duricova D, Lenicek M, Elkjaer M, Bortlik M, Andersen PS, Vitek L, Davidsen B, Wewer V, Lukas M, Munkholm P. Infliximab dependency is related to decreased surgical rates in adult Crohn's disease patients. Eur J Gastroenterol Hepatol 2010;22:1196-203. IF = ,662
Lin JP, Vitek L, Schwertner HA.Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem 2010;56:1535-43. IF = 6,263
Vítek L, Zelenková M, Brůha R Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. Vítek L, Zelenková M, Brůha R. Dig Liver Dis. 2010;42:911-2. IF=2,972
Vítek L, Muchová L, Jančová E, Pešičková S, Tegzová D, Peterová V, Pavelka K, Tesař V. Scand J Association of systemic lupus erythematosus with low serum bilirubin levels. Rheumatol 2010;39:480-4. IF = 2,507
Petr T, Smíd V, Smídová J, Hůlková H, Jirkovská M, Elleder M, Muchová L, Vitek L, Smíd F. Histochemical detection of GM1 ganglioside using cholera toxin-B subunit. Evaluation of critical factors optimal for in situ detection with special emphasis to acetone pre-extraction. Eur J Histochem 2010;54:e23. IF = 1,77
Hradsky O, Dusatkova P, Lenicek M, Bronsky J, Nevoral J, Vitek L, Lukas M, Zeniskova I, Cinek O. The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in developent of Crohn's disease. BMC Med Genet 2010 Jun 10;11:91. IF = 2,840
Muchova L, Vanova K, Zelenka J, Lenicek M, Petr T, Vejrazka M, Sticova E, Vreman HJ, Wong RJ, Vitek L. Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress. J Cell Mol Med. 2010 May 28. [Epub ahead of print]. IF = 5,228
Taha H, Skrzypek K, Guevara I, Nigisch A, Mustafa S, Grochot-Przeczek A, Ferdek P, Was H, Kotlinowski J, Kozakowska M, Balcerczyk A, Muchova L, Vitek L, Weigel G, Dulak J, Jozkowicz A.Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol 2010;30:1634-41. IF = 7,235
Vítek L, Novotná M, Lenícek M, Novotný L, Eberová J, Petrásek J, Jirsa M. Serum bilirubin levels and UGT1A1 promoter variations in patients with schizophrenia. Psychiatry Res 2010;178:449-50. IF = 2,373
Lee HJ, Kim HC, Vitek L, Nam CM. Algae consumption and risk of type 2 diabetes: Korean National Health and Nutrition Examination Survey in 2005. J Nutr Sci Vitaminol (Tokyo) 2010;56:13-8. IF = 0,929
Jiraskova A, Lenicek M, Vitek L. Simultaneous genotyping of microsatellite variations in HMOX1 and UGT1A1 genes using multicolored capillary electrophoresis. Clin Biochem 2010;43:697-9. IF=2,019
Kovár J, Lenícek M, Zimolová M, Vítek L, Jirsa M, Pitha J. Regulation of diurnal variation of cholesterol 7alpha-hydroxylase (CYP7A1) activity in healthy subjects. Physiol Res 2010;59:233-8. IF = 1,430
Schreuder TC, Marsman HA, Lenicek M, van Werven JR, Nederveen AJ, Jansen PL, Schaap FG. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol 2010;298:G440-5. IF = 3,258
Jiskra J, Limanova Z, Vanickova Z, Kocna P.: IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy. Physiological Research 2003, 52: (1) 79-88 PDF full text
Kocna, P.; Frič, P.; Zavoral, M.; Pelech, T.:Arginase activity determination - A marker of large bowel mucosa proliferation. European Journal of Clinical Chemistry and Clinical Biochemisty, 1996, 34, 8, 619-623 PDF full text
Tučková, L.; Tlaskalová-Hogenová, H.; Farré, M.A.; Karská, K.; Rossmann, P.; Kolínská, J.; Kocna, P.:Molecular mimicry as a possible cause of autoimmune reactions in celiac disease? Antibodies to gliadin cross-react with epitopes on enterocytes.Clinical Immunology and Immunopathology, 1995, 74, 2, 170-176 PDF full text
Frič, P.; Slabý, J.; Kasafírek, E.; Kocna, P.; Marek, J.:Effective Peritoneal Therapy of Acute Pancreatitis in the Rat with Glutaryl-Trialanin-Ethylamide - A Novel Inhibitor of Pancreatic Elastase. Gut, 1992, 33, 5, 701-706 PDF full text
Kovářová J.T., Zavoral M., Zima T., Žák A., Kocna P., Kohout P., Granátová J., Vaníčková Z., Vránová J., Suchánek S., Beneš Z., Čelko M.A., Povýšil C.: Improvements in colorectal cancer screening programmes – quantitative immunochemical faecal occult blood testing – how to set the cut-off for a particular population. Biomed Pap 2012, 156(2):143-150 - PDF soubor
Year 2011:
Was H., Sokolowska M., Sierpinowska A., Dominik P., Skrzypek K., Lackowska B., Pratnicki A., Grochot-Przeczek A., Taha H., Kotlinowski J., Kozakowska M., Mazan A., Nowak W., Muchová L., Vitek L., Ratajska A., Dulak J., Jozkowicz A. Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice. Free Radic Biol Med 2011; 51(9):1717-1726
Vítek L, Muchová L, Zák A. Statin use and serum bilirubin levels. Atherosclerosis 2011;219:969.
Urbánek P, Leníček M, Muchová L, Subhanová I, Dušek L, Kaspříková N, Hrabal P, Bruha R, Vítek L: No association of promoter variations of HMOX1 and UGT1A1 genes with liver injury in chronic hepatitis C. Ann Hepatol. 2011, 10(4):445-51. IF = 1,811.
Šmíd F., Ledvinová J., Petr T., Šmídová J., Vítek L.: Methods based on binding affinity of the B-subunit of cholera toxin to gangliosides in biochemistry and histology. Nova Science Publishers, Inc., New York 2011, str. 89 -108
Muchova L, Vanova K, Zelenka J, Lenicek M, Petr T, Vejrazka M, Sticova E, Vreman HJ, Wong RJ, Vitek L. Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress. J Cell Mol Med 2011;15:1156-1165. IF = 4,125.
Hradský O, Dušátková P, Leníček M, Bronský J, Ďuricová D, Nevoral J, Vítek L, Lukáš M, Cinek O. Two independent genetic factors responsible for the associations of the IBD5 locus with Crohn’s disease in the Czech population. Inflamm Bowel Dis 2011;17(7): 1523-9. IF = 4,855.
Leníček M, Ďuricová D, Komárek V, Gabryšová B, Lukáš M, Šmerhovský Z, Vítek L. Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers. Inflamm Bowel Dis 2011;17(6):1322-1327. IF = 4,855.
Gutiérrez-Grobe Y, Vitek L, Tiribelli C, Kobashi-Margáin RA, Uribe M, Méndez-Sánchez N. Biliverdin and heme oxygenase antiviral activity against hepatitis C virus. Ann Hepatol 2011;10:105-7.
Gabrovská D., Kocna P., Rysová J., Borovská D.,Tlaskalová-Hogenová H.: Monitoring of Daily Gliadin Intake in Patients on Gluten-free Diets. Prague Medical Report 2011, 112 (1): 5 – 17 PDF soubor
Fode P, Jespersgaard C, Hardwick RJ, Bogle H, Theisen M, Dodoo D, Leníček M, Vítek L, Vieira A, Freitas J, Andersen PS, Hollox EJ. Determination of Beta-defensin genomic copy number in different populations: a comparison of three methods. PLoS One 2011;6(2):e16768. IF = 4,092.
Duricova D, Jakobín C, Lenicek M, Lukas M, Munkholm P, Pedersen N, Weber V: The clinical implication of drug dependency in children and adults with inflammatory bowel disease: A review. Journal of Crohn's and Colitis 2011; Vol. 5, Issue 2: 81-90. IF = 2,566.
Černý D, Lekić N, Váňová K, Muchová L, Hořínek A, Kmoníčková E, Zídek Z, Kameníková L, Farghali H: Hepatoprotective effect of curcumin in lipopolysaccharide/D-galactosamine model of liver injury in rats: Relationship to HO-1/CO antioxidant system, Fitoterapia 2011;82:786–791.
Year 2010:
Lenicek M, Duricova D, Komarek V, Gabrysova B, Lukas M, Smerhovsky Z, Vitek L.: Bile acid malabsorption in inflammatory bowel disease: Assessment by serum markers. Inflamm Bowel Dis 2011 Jun;17(6):1322-7. doi: 10.1002/ibd.21502. Epub 2010 Nov 5. IF = 4,643
Bruha R, Marecek Z, Pospisilova L, Nevsimalova S, Vitek L, Martasek P, Nevoral J, Petrtyl J, Urbanek P, Jiraskova A, Ferenci P.: Long-term follow-up of Wilson Disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver Int. 2011 Jan;31(1):83-91. doi: 10.1111/j.1478-3231.2010.02354.x. Epub 2010 Oct 20. IF = 2,987
Nevsimalova S, Buskova J, Bruha R, Kemlink D, Sonka K, Vitek L, Marecek Z Sleep disorders in Wilson's disease. Eur J Neurol. 2011 Jan;18(1):184-90. doi: 10.1111/j.1468-1331.2010.03106.x.. IF = 2,510
Meggyesi N, Kiss LS, Koszarska M, Bortlik M, Duricova D, Lakatos L, Molnar T, Leniček M, Vítek L, Altorjay I, Papp M, Tulassay Z, Miheller P, Papp J, Tordai A, Andrikovics H, Lukas M, Lakatos PL. NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients. World J Gastroenterol 2010;16:5233-40. IF=2,092
Vítek L. Elevated bilirubin in acute and transient psychotic disorder. Pharmacopsychiatry 2010;43:285. IF = 2,317
Pedersen N, Duricova D, Lenicek M, Elkjaer M, Bortlik M, Andersen PS, Vitek L, Davidsen B, Wewer V, Lukas M, Munkholm P. Infliximab dependency is related to decreased surgical rates in adult Crohn's disease patients. Eur J Gastroenterol Hepatol 2010;22:1196-203. IF = ,662
Lin JP, Vitek L, Schwertner HA.Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem 2010;56:1535-43. IF = 6,263
Vítek L, Zelenková M, Brůha R Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. Vítek L, Zelenková M, Brůha R. Dig Liver Dis. 2010;42:911-2. IF=2,972
Vítek L, Muchová L, Jančová E, Pešičková S, Tegzová D, Peterová V, Pavelka K, Tesař V. Scand J Association of systemic lupus erythematosus with low serum bilirubin levels. Rheumatol 2010;39:480-4. IF = 2,507
Petr T, Smíd V, Smídová J, Hůlková H, Jirkovská M, Elleder M, Muchová L, Vitek L, Smíd F. Histochemical detection of GM1 ganglioside using cholera toxin-B subunit. Evaluation of critical factors optimal for in situ detection with special emphasis to acetone pre-extraction. Eur J Histochem 2010;54:e23. IF = 1,77
Hradsky O, Dusatkova P, Lenicek M, Bronsky J, Nevoral J, Vitek L, Lukas M, Zeniskova I, Cinek O. The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in developent of Crohn's disease. BMC Med Genet 2010 Jun 10;11:91. IF = 2,840
Muchova L, Vanova K, Zelenka J, Lenicek M, Petr T, Vejrazka M, Sticova E, Vreman HJ, Wong RJ, Vitek L. Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress. J Cell Mol Med. 2010 May 28. [Epub ahead of print]. IF = 5,228
Taha H, Skrzypek K, Guevara I, Nigisch A, Mustafa S, Grochot-Przeczek A, Ferdek P, Was H, Kotlinowski J, Kozakowska M, Balcerczyk A, Muchova L, Vitek L, Weigel G, Dulak J, Jozkowicz A.Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol 2010;30:1634-41. IF = 7,235
Vítek L, Novotná M, Lenícek M, Novotný L, Eberová J, Petrásek J, Jirsa M. Serum bilirubin levels and UGT1A1 promoter variations in patients with schizophrenia. Psychiatry Res 2010;178:449-50. IF = 2,373
Lee HJ, Kim HC, Vitek L, Nam CM. Algae consumption and risk of type 2 diabetes: Korean National Health and Nutrition Examination Survey in 2005. J Nutr Sci Vitaminol (Tokyo) 2010;56:13-8. IF = 0,929
Jiraskova A, Lenicek M, Vitek L. Simultaneous genotyping of microsatellite variations in HMOX1 and UGT1A1 genes using multicolored capillary electrophoresis. Clin Biochem 2010;43:697-9. IF=2,019
Kovár J, Lenícek M, Zimolová M, Vítek L, Jirsa M, Pitha J. Regulation of diurnal variation of cholesterol 7alpha-hydroxylase (CYP7A1) activity in healthy subjects. Physiol Res 2010;59:233-8. IF = 1,430
Schreuder TC, Marsman HA, Lenicek M, van Werven JR, Nederveen AJ, Jansen PL, Schaap FG. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol 2010;298:G440-5. IF = 3,258
Starší práce, citované, s plným textem v PDF:
Jiskra J, Limanova Z, Vanickova Z, Kocna P.: IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy. Physiological Research 2003, 52: (1) 79-88 PDF full text
Kocna, P.; Frič, P.; Zavoral, M.; Pelech, T.:Arginase activity determination - A marker of large bowel mucosa proliferation. European Journal of Clinical Chemistry and Clinical Biochemisty, 1996, 34, 8, 619-623 PDF full text
Tučková, L.; Tlaskalová-Hogenová, H.; Farré, M.A.; Karská, K.; Rossmann, P.; Kolínská, J.; Kocna, P.:Molecular mimicry as a possible cause of autoimmune reactions in celiac disease? Antibodies to gliadin cross-react with epitopes on enterocytes.Clinical Immunology and Immunopathology, 1995, 74, 2, 170-176 PDF full text
Frič, P.; Slabý, J.; Kasafírek, E.; Kocna, P.; Marek, J.:Effective Peritoneal Therapy of Acute Pancreatitis in the Rat with Glutaryl-Trialanin-Ethylamide - A Novel Inhibitor of Pancreatic Elastase. Gut, 1992, 33, 5, 701-706 PDF full text
02.11.2012 |
|
zpět na Publications
